Record Display for the EPA National Library Catalog

RECORD NUMBER: 6 OF 9

OLS Field Name OLS Field Data
Main Title Hyperactivity Induced by Triadimefon, a Triazole Fungicide (Journal Version).
Author Crofton, K. M. ; Boncek, V. M. ; Reiter, L. W. ;
CORP Author Health Effects Research Lab., Research Triangle Park, NC. ;Northrop Services, Inc./Environmental Sciences, Research Triangle Park, NC.
Publisher c1988
Year Published 1988
Report Number EPA/600/J-88/070;
Stock Number PB89-109888
Additional Subjects Toxicity ; Fungicides ; Triazoles ; Animal behavior ; Laboratory animals ; Nitrogen heterocyclic compounds ; Chlorine organic compounds ; Reprints ; Triadimefon ; Dose-response relationships ; Butanone/chlorophenoxy-dimethyl-triazolyl ; CAS 43121-43-3 ; Motor activity
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB89-109888 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. 03/14/1989
Collation 9p
Abstract
Triadimefon is an agriculturally important triazole fungicide. Experiments were conducted to characterize the behavioral toxicity of triadimefon using a measure of motor activity. Male Long Evans hooded rats, approximately 70 days old, received triadimefon po in 2.0 ml/kg corn oil. Motor activity testing was conducted for 1 hr in figure-eight mazes. For the dosage-effect determination triadimefon (50-400 mg/kg) was administered 1 hr prior to testing. In the time-course study, triadimefon (200 mg/kg) was administered either 0.5, 1, 2, 4, 8, or 24 hr prior to testing. In the repeated dosing experiment animals received triadimefon (100 mg/kg) daily for seven days and were tested 24 hr after the last exposure. Triadimefon produced significant hyperactivity following dosages of 100 and 200 mg/kg. The hyperactivity was rapid in both onset (0.5 hr) and recovery (8.0 hr). Repeated dosing with 100 mg/kg/day revealed no cumulative effects nor tolerance. The results indicate that triadimefon produces a transient hyperactivity at dosages 17 to 33% of the reported LD50. (Copyright (c) 1988 by The Society of Toxicology.)